Channel 3 Educational session

Novel immunotherapeutic platforms

Date
11.12.2020
Time
15:25 - 16:45
Channel
Channel 3
Chairs
  • Thomas Powles (London, United Kingdom)
39 - Novel immunotherapeutic platforms Educational session

At the intersection of science and engineering: Novel platform approaches to immunotherapy

Lecture Time
15:25 - 15:40
Speakers
  • Daniel S. Chen (Mountain View, CA, United States of America)
Session Name
39 - Novel immunotherapeutic platforms
Channel
Channel 3
Date
11.12.2020
Time
15:25 - 16:45
Authors
  • Daniel S. Chen (Mountain View, CA, United States of America)
39 - Novel immunotherapeutic platforms Educational session

Rational STING agonist combination therapy

Lecture Time
15:40 - 15:55
Speakers
  • Sebastian Carotta (Vienna, Austria)
Session Name
39 - Novel immunotherapeutic platforms
Channel
Channel 3
Date
11.12.2020
Time
15:25 - 16:45
Authors
  • Sebastian Carotta (Vienna, Austria)
39 - Novel immunotherapeutic platforms Educational session

Inhibition of GARP-TGF-?1 activation by Tregs overcomes resistance to PD-1/PD-L1 blockade in cancer

Lecture Time
15:55 - 16:10
Speakers
  • Sophie Lucas (Woluwe-Saint-Lambert, Belgium)
Session Name
39 - Novel immunotherapeutic platforms
Channel
Channel 3
Date
11.12.2020
Time
15:25 - 16:45
Authors
  • Sophie Lucas (Woluwe-Saint-Lambert, Belgium)
39 - Novel immunotherapeutic platforms Educational session

Opportunities for antisense oligonucleotide-based therapies within immuno-oncology

Lecture Time
16:10 - 16:25
Speakers
  • Frank Jaschinski (Marburg, Germany)
Session Name
39 - Novel immunotherapeutic platforms
Channel
Channel 3
Date
11.12.2020
Time
15:25 - 16:45
Authors
  • Frank Jaschinski (Marburg, Germany)
39 - Novel immunotherapeutic platforms Educational session

Q&A and live discussion

Lecture Time
16:25 - 16:41
Speakers
  • All Speakers (, United States of America)
Session Name
39 - Novel immunotherapeutic platforms
Channel
Channel 3
Date
11.12.2020
Time
15:25 - 16:45
Authors
  • All Speakers (, United States of America)